Philippe Armand
Hematologist / Oncologist · Mayo Clinic College of Medicine and Science
Credentials: · · · · · · ·
History
- 2000–2003
Internal Medicine
Research
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma
New England Journal of Medicine · 2015 · Last of 19 authors · 2,937 citations
Interleukin-2 and regulatory T cells in graft-versus-host disease
New England Journal of Medicine · 2011 · 929 citations
Journal of Clinical Oncology · 2016 · 869 citations
90 papers
89 papers
86 papers
81 papers
80 papers
78 papers · 5 as a fellow
63 papers
50 papers
Grants
- 1997–2030
Mayo Clinic Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $705.8K · Mayo Clinic Rochester
- 1997–2000
Resource for Biocomputing, Visualization, and Informatics
National Center for Research Resources · P41
Project lead · $12.2K · University of California, San Francisco
Clinical trials
- 2013–2014
CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma
Principal investigator · Terminated · Phase 2
Dana-Farber Cancer Institute
- 2009–2014
Principal investigator · Completed · Phase 3
Dana-Farber Cancer Institute
- 2008–2011
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
Principal investigator · Terminated
Dana-Farber Cancer Institute
- 2008–2011
Observational Study of Iron Overload in Stem Cell Transplantation
Principal investigator · Completed
Dana-Farber Cancer Institute